Phase II Trial of Saracatinib (AZD0530), an Oral...

Clinical Breast Cancer 2011 Vol. 11; Iss. 5

Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer

Ayca Gucalp, Joseph A. Sparano, James Caravelli, Jean Santamauro, Sujata Patil, Alyson Abbruzzi, Christine Pellegrino, Jackie Bromberg, Chau Dang, Maria Theodoulou, Joan Massague, Larry Norton, Cliffo
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2011
Language:
english
Pages:
6
DOI:
10.1016/j.clbc.2011.03.021
File:
PDF, 477 KB
english, 2011
Conversion to is in progress
Conversion to is failed